LEARNING OBJECTIVES


At the conclusion of this activity, participants will be able to:


1. Discuss a method to identify clinically relevant subgroups in scleroderma

2. Describe an example from the study of cancer-induced autoimmunity in scleroderma

3. Propose a framework to foster development of personalized medicine strategies in scleroderma and other complex rheumatic diseases

Session date: 
03/29/2022 - 8:30am to 9:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ami Shah, M.D. & Ji Soo Kim, Ph.D.